LUPO, Luigi Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.759
EU - Europa 1.354
AS - Asia 596
SA - Sud America 6
OC - Oceania 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.726
Nazione #
US - Stati Uniti d'America 4.743
CN - Cina 427
DE - Germania 329
SE - Svezia 312
UA - Ucraina 192
IT - Italia 163
SG - Singapore 108
FI - Finlandia 107
GB - Regno Unito 97
FR - Francia 63
RU - Federazione Russa 31
IN - India 25
BE - Belgio 24
IR - Iran 15
CA - Canada 14
IE - Irlanda 10
NL - Olanda 10
AU - Australia 5
MK - Macedonia 4
TR - Turchia 4
VN - Vietnam 4
BR - Brasile 3
PL - Polonia 3
RO - Romania 3
CL - Cile 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
ID - Indonesia 2
JP - Giappone 2
KZ - Kazakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
EE - Estonia 1
ES - Italia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
RS - Serbia 1
Totale 6.726
Città #
Fairfield 587
Chandler 505
Jacksonville 447
Woodbridge 401
Ashburn 315
Cambridge 261
Nyköping 258
Houston 242
Seattle 232
Ann Arbor 226
Wilmington 226
Lawrence 110
Roxbury 109
Nanjing 100
Beijing 88
Singapore 86
Des Moines 76
Boardman 60
New York 51
Princeton 48
Shenyang 46
Bari 45
Inglewood 42
Jiaxing 33
San Diego 28
Brooklyn 27
Nanchang 25
Brussels 24
Dearborn 24
Eboli 22
Marseille 21
Tianjin 20
Los Angeles 19
Hebei 17
Santa Clara 16
Paris 15
Redwood City 15
San Francisco 15
Changsha 14
Ardabil 12
Toronto 12
Augusta 11
London 11
Dublin 10
Guangzhou 10
Falls Church 9
Leawood 9
San Mateo 9
Hangzhou 8
Jinan 8
Norwalk 8
Pune 8
Washington 8
Grafing 7
Zhengzhou 7
Auburn Hills 6
Amsterdam 5
Mola Di Bari 5
Mumbai 5
Ningbo 5
Rome 5
Helsinki 4
Taizhou 4
Fuzhou 3
Hefei 3
Kilburn 3
Monmouth Junction 3
Shanghai 3
Sydney 3
Altamura 2
Baotou 2
Bisceglie 2
Bitola 2
Cairo 2
Castel Maggiore 2
Esanatoglia 2
Florence 2
Fossano 2
Groningen 2
Indiana 2
Islington 2
Kunming 2
Marano Di Napoli 2
Molfetta 2
Montreal 2
Novokuznetsk 2
Nürnberg 2
Palermo 2
Pisa 2
Pittsburgh 2
Qingdao 2
Shenzhen 2
Skopje 2
Stimigliano 2
Tappahannock 2
Tokyo 2
Triggiano 2
Turin 2
Warsaw 2
Almaty 1
Totale 5.161
Nome #
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC 126
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 116
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 114
Protective colostomy closure: the hazards of a "minor" operation 110
Targeting angiogenesis in biliary tract cancers: An open option 109
TROMBOPOIETINA E PIASTRINOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO (OLT):RISULTATI PRELIMINARI SU 21 PAZIENTI 108
Improved accuracy of computed tomography in local staging of rectal cancer using water enema 107
Clinical role of tissue and serum levels of SCCA antigen in hepatocellular carcinoma 100
Reliability of clinical judgement in evaluation of the nutritional status of surgical patients 98
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 96
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma 96
Is pyloric function preserved in pylorus-preserving pancreaticoduodenectomy? 93
D-MELD, a strong and accurate tool to guide Donor -2- Recipient Matching 91
Lipoprotein(a), lipids and proinflammatory cytokines in patients undergoing major abdominal surgery 88
Prediction of mortality by logistic regression analysis in patients with postoperative enterocutaneous fistulae. 88
null 86
null 81
MELD predictive value of alterations of brain perfusion during liver transplantation 80
Randomized clinical trial of radiofrequency-assisted versus clamp-crushing liver resection 80
Facing HCV recurrence after liver transplantation: antiviral therapy response and clinical out come 78
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? 77
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients 77
Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C. 77
null 76
Resection vs radiofrequency ablation for HCC from 3 to 5 cm: A single centre experience on 101 child- pugh class A-B naive patients 75
Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial 74
Plasma concentrations but not serum concentrations of brain-derived neurotrophic factor are related to pro-inflammatory cytokines in patients undergoing major abdominal surgery 71
Laparoscopic management of neuroendocrine tumors: State-of-the-art 70
null 70
Accuratezza diagnostica dello staging dell’HCC nei pazienti con cirrosi: la lezione dei trapianti di fegato 68
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 68
Tempo di ischemia fredda e produzione di trombopoietina(TPO) nel trapianto ortotopico di fegato: risultati preliminari su 21 casi 67
Solutions for organ perfusion and storage: haemorheologic aspects 67
A national mandatory-split liver policy: A report from the Italian experience 67
RECTAL-CARCINOMA - CT STAGING WITH WATER AS CONTRAST-MEDIUM 66
Elective versus emergency full thickness rectal prolapse treatment using a perineal approach - a video vignette 66
State of lucid delirium after orthotopic liver transplantation. Clinical case 65
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 65
THE UN-SUSTAINABLE MATCH IN HCV LIVER TRANSPLANT PATIENTS 65
null 63
A Bayesan methodology to improve of early graft loss after liver transplantation derived from the Liver Match study 63
Behind D-MELD :the role of primary indication (HCV or HBV) as significant Covariate in the Outcome Prediction after Liver Transplant 62
LIVER RELATED EVENTS (LRE) IN PATIENTS WITH ESTABLISHED HCV RECURRENT DISEASE AFTER LIVER TRANSPLANTATION COULD BE PREDICTED BY LIVER STIFFNESS MEASUREMENT (LSM). 61
TROMBOPOIETINA (TPO) E TROMBOCITOPENIA NEI PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO: STUDIO PRELIMINARE SU 9 CASI 61
STATE OF LUCID DELIRIUM AFTER ORTHOTOPIC LIVER TRANSPLANTATION 60
Hepatocellular carcinoma progression is accelerated by cancer associated fibroblasts stimulated by tumor production of lysophosphatidic acid 60
Radiofrequency ablation of HCC on liver cirrhosis. Evaluation of effect by spiral-CT and pathology on native livers of trasplanted patients 60
Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after Intralipid infusion in rabbits 58
Safe use of Grafts from HBcAb Positive Donors in Liver Transplantation -Analysis of Matching and Outcome 58
The tumor microenvironment regulates HCC growth rate 58
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC 57
Postoperative changes in serum interleukin-2 concentrations 57
Prognostic Value of Neutrophil/Lymphocyte Ratio in Liver Transplantation for HCC 56
ACUTE PANCREATITIS AFTER ORTOTOPIC LIVER TRANSPLANTATION 56
Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage 56
Manuale di Metodologia della Ricerca ClinicA 55
Reduction of postoperative immunosuppression with ranitidine in patients with cancer of the stomach or large bowel 54
Liver Match, a prospective observational cohort study on liver transplantation in Italy: Study design and current practice of donor-recipient matching 54
EFFECT OF PERIOPERATIVE WHOLE BLOOD VS LEUCOCYTE-DEPLETED BLOOD TRANSFUSION ON SURVIVAL AFTER CURATIVE SURGERY FOR COLORECTAL 54
OPTIMIZATION OF DONOR-RECIPIENT MATCH AND IDENTIFICATION OF THE FUTILE MATCH CUTOFF. A NATIONAL ITALIAN STUDY ON LIVER TRANSPLANTATION. 53
D-MELD, a powerful Instrument to Optimize Donor -2-Recipient Match.Differences betweenUS and Italy 53
Terapia fibrinolitica nel trattamento delle ulcere venose post-flebitiche 52
Tempo di ischemia fredda e produzione di trombopoietina(TPO)nel trapianto ortotopico di fegato (OLT): studio preliminare sui primi 9 casi. 52
TROMBOPOIETINA E PIASTRINOPENIA NEI PZ. SOTTOPOSTI A TRAPIANTO DI FEGATO(OLT): RISULTATI PRELIMINARI SU 21 PZ 51
null 51
Limited prognostic value of staging systems for hepatocellular carcinoma on cirrhosis 50
Platelets and hepatocellular cancer: Bridging the bench to the clinics 50
RUOLO DEL TIPO DI PERFUSIONE NEL PRELIEVO DI FEGATO A SCOPO DI TRAPIANTO 49
Laminin-5 stimulates hepatocellular carcinoma growth through a different function of alpha 6 beta 4 and alpha 3 beta 1 integrins 47
Role of perioperative parenteral nutrition in patients submitted to curative surgery for gastric carcinoma. 47
Down-staging in Liver Transplantation for HCC 46
Reliability and accuracy of the hepatic perfusion index as a diagnostic test for liver metastases. 46
PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma 46
Irisin improves the secretory defects of pancreatic islets from type 2 diabetic subjects 46
Worse Graft Survival in HCV-Infected Transplanted Females Receiving a Male Donor Graft. The Liver Match Study 45
Liver transplantation with hepatitis B core antibodypositive graft under hepatitis b Immunoglobulin and lamivudine prophilaxis 45
STUDIO DELL'MCP-1 (MONOCYTE CHEMOATTRACTANT PROTEIN) NEL TRAPIANTO DI FEGATO 45
Azione della pentossifillina sulla evoluzione in guarigione delle ferite sperimentali nel coniglio 45
Basiliximab vs Steroids in liver transplantation immunosuppression. A prospective randomized clinical trial. 44
null 43
null 43
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment 43
null 41
[Blood flow assessment with Doppler color ultrasonography in primary and secondary tumors of the liver]. FT Valutazioni flussimetriche con eco color Doppler nei tumori epatici primitivi e secondari. 41
Valutazione prognostica delle fistole enterocutanee post operatorie: confronto fra due sistemi prognostici 41
Fattori prognostici nel trattamento sclerosante delle varici esofagee sanguinanti: Studio preliminare 41
Evaluation of RFA of HCC in patients underwent LTx: Spiral-CT and Pathology on native livers 41
Hepatitis B-core antibody positive donors in Liver Trasplantation and their impact on graft survival:Evidence from the Liver Match cohort study 41
HSP70 and VEGF blood levels in patients with hepatocellular carcinoma (HCC) 40
Reliability of clinical judgement in evaluation of the nutritional-status of surgial patients. 40
null 40
Post-surgical trauma acute inflammation. A molecular analysis 38
Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosi in 961 patients 37
Resection vs radiofrequency ablation for HCC from 3 to 5cm: A single centre experience on 101 child-pugh class A-B naive patients 37
Risk of seeding and metastasis in the thoracic or abdomianl wall due to RFA and biopsy of HCC on cirrhosis.Single centre experience. Cutionary note 35
Liver Transplantation vs Resection for patients with HCC within Milan Criteria 34
Pushing the limits: Liver Transplantation for HCC beyond the Milan Criteria in the MELD Era (Attraction of forbidden or a rational approach) 33
[Gene expression of the MAGE-1, -3, and -6 antigens in hepatic carcinoma]. FT Espressione genica degli antigeni MAGE-1, -3, -6 nell'epatocarcinoma. 33
Gene expression of tha MAGE-1,-3 and 6 antigens in hepatic carcinoma 33
Reliable Steroid-Free Immunosuppression in Liver Transplantation 32
Totale 6.209
Categoria #
all - tutte 30.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.332 0 0 46 148 181 109 197 138 203 117 158 35
2020/20211.011 111 52 95 52 103 46 92 53 119 120 107 61
2021/2022854 20 133 10 47 22 50 41 52 39 38 138 264
2022/20231.350 182 120 84 118 162 196 18 154 245 7 33 31
2023/2024413 33 83 24 37 40 94 21 23 0 6 11 41
2024/2025186 24 22 140 0 0 0 0 0 0 0 0 0
Totale 6.832